Applied Genetic Technologies Corporation Expands Its Clinical and Regulatory Expertise with Appointment of Jeffrey Chulay M.D. as Vice President and Chief Medical Officer  
7/9/2007 11:02:56 AM

ALACHUA, Fla.--(BUSINESS WIRE)--AGTC (Applied Genetic Technologies Corporation), a privately held clinical stage gene therapy company, is pleased to announce that Dr. Jeffrey Chulay has joined the company as Chief Medical Officer and Vice President of Regulatory Affairs.